Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination.
Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis.
Commentary: Outcome measures were flawed.
Significant Reduced Loss of Brain Volume in Multiple Sclerosis Patients Treated with COPAXONE(R)
Sanofi's history
Estimating a treatment effect: Choosing between relative and absolute measures.
The transcriptome of mouse central nervous system myelin.
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial.
The Histology of Disseminated Sclerosis
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.
ChemIDplus Advanced
Eight cases of insular sclerosis of the brain and spinal cord.
Pathological Anatomy: Illustrations of the elementary forms of disease.
Multiple Sklerose und Erbanlage
Switching from natalizumab to fingolimod: an observational study.
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.
Multiple sclerosis from the standpoint of geographic distribution and race
Disseminated sclerosis in South Africa; its relationship to swayback disease and suggested treatment.
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.
Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables.
Critical Review: disseminated sclerosis
Gray matter atrophy is related to long-term disability in multiple sclerosis.
ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study): A Randomized, Double-Blind, Placebo-Controlled Trial.
MRI as an outcome in multiple sclerosis clinical trials.
The influence of nutritional factors on the prognosis of multiple sclerosis.
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
